346 related articles for article (PubMed ID: 26151848)
1. Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).
Li Y; Eskelund AR; Zhou H; Budac DP; Sánchez C; Gulinello M
Int J Mol Sci; 2015 Jul; 16(7):15150-71. PubMed ID: 26151848
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
[TBL] [Abstract][Full Text] [Related]
3. Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus.
Reynolds J; Huang M; Li Y; Meineck M; Moeckel T; Weinmann-Menke J; Mohan C; Schwarting A; Putterman C
J Neuroinflammation; 2024 Apr; 21(1):89. PubMed ID: 38600510
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
Front Immunol; 2018; 9():2189. PubMed ID: 30319641
[TBL] [Abstract][Full Text] [Related]
5. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
6. The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.
Gulinello M; Putterman C
J Biomed Biotechnol; 2011; 2011():207504. PubMed ID: 21331367
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
[TBL] [Abstract][Full Text] [Related]
8. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
[TBL] [Abstract][Full Text] [Related]
9. Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus.
Lu F; Lu H; Xie M; Li S; Zu Y; Zhou J; Yu J; Wang S; Ruan Y; Wen C; Xu Z
Inflammopharmacology; 2019 Jun; 27(3):511-520. PubMed ID: 30911862
[TBL] [Abstract][Full Text] [Related]
10. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
11. A Distinct T Follicular Helper Cell Subset Infiltrates the Brain in Murine Neuropsychiatric Lupus.
Jain S; Stock A; Macian F; Putterman C
Front Immunol; 2018; 9():487. PubMed ID: 29593732
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal damage in mouse and human forms of systemic autoimmune disease.
Ballok DA; Woulfe J; Sur M; Cyr M; Sakic B
Hippocampus; 2004; 14(5):649-61. PubMed ID: 15301441
[TBL] [Abstract][Full Text] [Related]
13. FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus.
Shi D; Tian T; Yao S; Cao K; Zhu X; Zhang M; Wen S; Li L; Shi M; Zhou H
Brain Behav Immun; 2018 May; 70():293-304. PubMed ID: 29548997
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
15. Absence of functional alternative complement pathway alleviates lupus cerebritis.
Alexander JJ; Jacob A; Vezina P; Sekine H; Gilkeson GS; Quigg RJ
Eur J Immunol; 2007 Jun; 37(6):1691-701. PubMed ID: 17523212
[TBL] [Abstract][Full Text] [Related]
16. The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus.
Moore E; Huang MW; Jain S; Chalmers SA; Macian F; Putterman C
Front Immunol; 2020; 11():1476. PubMed ID: 32765512
[No Abstract] [Full Text] [Related]
17. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus.
Tomita M; Khan RL; Blehm BH; Santoro TJ
Med Hypotheses; 2004; 62(3):325-35. PubMed ID: 14975498
[TBL] [Abstract][Full Text] [Related]
18. Treatment with lysophosphatidic acid prevents microglial activation and depression-like behaviours in a murine model of neuropsychiatric systemic lupus erythematosus.
Nagata W; Koizumi A; Nakagawa K; Takahashi S; Gotoh M; Satoh Y; Ishizuka T
Clin Exp Immunol; 2023 Apr; 212(2):81-92. PubMed ID: 36718978
[TBL] [Abstract][Full Text] [Related]
19. A Novel Microglia-Specific Transcriptional Signature Correlates With Behavioral Deficits in Neuropsychiatric Lupus.
Makinde HM; Winter DR; Procissi D; Mike EV; Stock AD; Kando MJ; Gadhvi GT; Droho S; Bloomfield CL; Dominguez ST; Mayr MG; Lavine JA; Putterman C; Cuda CM
Front Immunol; 2020; 11():230. PubMed ID: 32174913
[TBL] [Abstract][Full Text] [Related]
20. Remodeling of Neurotransmission, Chemokine, and PI3K-AKT Signaling Genomic Fabrics in Neuropsychiatric Systemic Lupus Erythematosus.
Iacobas D; Wen J; Iacobas S; Schwartz N; Putterman C
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33578738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
